Food Science and Agriculture: Research Highlights Vol. 8

Foods contain, beyond their macronutrient and micronutrient content, a heterogeneous group of secondary plant metabolites and animal-derived molecules collectively termed bioactive compounds, including polyphenols, carotenoids, glucosinolates, phytosterols, bioactive peptides and long-chain polyunsaturated fatty acids. Interest in these compounds has grown substantially as epidemiological, mechanistic and clinical research has accumulated, yet the evidence base remains fragmented across compound classes, disease outcomes and study designs, and existing reviews tend to address single compound families or narrow technological applications rather than integrating mechanism, bioavailability and clinical outcome across the field as a whole. This critical narrative review synthesises current literature on the classification, dietary sources, bioavailability, gut microbial metabolism and principal health associations of the major classes of food-derived bioactive compounds, together with the influence of food processing and delivery technologies on their retention and systemic exposure. Literature was identified through targeted searches of biomedical and food-science databases and citation searching of recent reviews, appraised for methodological quality and relevance, and synthesised thematically rather than as a study-by-study catalogue. The reviewed evidence indicates consistent, moderate-strength associations between polyphenol-rich whole foods and improvements in blood pressure and lipid parameters, between carotenoid intake and reduced risk of selected cancers and cardiovascular disease, and between soy isoflavone intake and modestly reduced cancer incidence, although effect sizes are frequently attenuated or absent for isolated extracts, for hard clinical endpoints and for cognitive and vascular outcomes. Substantial heterogeneity in dosing, formulation, trial duration and population characteristics limits the strength of causal inference across nearly all compound classes. Bioavailability, gut microbial biotransformation and food matrix effects emerge as recurring determinants of inconsistent findings across the literature. The review identifies methodological and mechanistic gaps that constrain translation of laboratory and epidemiological findings into dietary guidance and proposes priorities for standardised dosing, longer intervention periods and matrix-aware trial design.